US HB6301 | 2023-2024 | 118th Congress

Status

Spectrum: Moderate Partisan Bill (Democrat 16-3)
Status: Introduced on November 8 2023 - 25% progression
Action: 2023-11-08 - Referred to the House Committee on Education and the Workforce.
Pending: House Education And The Workforce Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Cancer Drug Parity Act of 2023

Sponsors


History

DateChamberAction
2023-11-08HouseReferred to the House Committee on Education and the Workforce.
2023-11-08HouseIntroduced in House

Same As/Similar To

SB2039 (Same As) 2023-06-15 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Subjects


US Congress State Sources


Bill Comments

feedback